John Tanner, DO
Addiction Medicine · Jacksonville Beach, FLNPI 1952337990
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,620 of the $29,097 with a category attached, or 74.3%. Braeburn Inc. accounts for 80.8% of it on its own, with 17 other manufacturers making up the rest. Among addiction medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $282.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braeburn Inc.$23K
- Kaleo, Inc.$2K
- Indivior Inc.$1K
- AbbVie$704
- Alkermes, Inc.$334
- Axsome Therapeutics, Inc.$328
- plus $1K from 12 others
What the payments were for
- Consulting fees$1,0504%
- Speaking & faculty fees$21,62074%
- Travel & lodging$2,7259%
- Food & beverage$3,70213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braeburn Inc. | 30 | $23,499 |
| Kaleo, Inc. | 3 | $1,941 |
| Indivior Inc. | 10 | $1,001 |
| AbbVie | 16 | $704 |
| Alkermes, Inc. | 8 | $334 |
| Axsome Therapeutics, Inc. | 10 | $328 |
| Teva Pharmaceuticals USA, Inc. | 3 | $225 |
| Idorsia Pharmaceuticals US Inc | 6 | $207 |
| Pfizer | 3 | $154 |
| Abiomed | 1 | $149 |
| Gilead | 1 | $128 |
| Pear Therapeutics (US), Inc. | 1 | $125 |
| Edwards Lifesciences | 1 | $100 |
| Orexo US, Inc. | 6 | $88 |
| Amgen | 1 | $42 |
| Bridgebio Pharma, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $21 |
| Novo Nordisk | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,097 in reported general payments places this provider in the 90th percentile of 101 addiction medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 96 | $18,407 |
| Naltrexone Hcl | 17 | $1,502 |
| Aripiprazole | 48 | $1,149 |
| Methadone Hcl | 11 | $673 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $574 |
| Quetiapine Fumarate | 21 | $512 |
| Bupropion XlBupropion Hcl | 36 | $489 |
| Doxepin Hcl | 23 | $464 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $392 |
| Gabapentin | 27 | $386 |
| Buspirone Hcl | 25 | $320 |
| Trazodone Hcl | 34 | $274 |
| Escitalopram Oxalate | 25 | $238 |
| Lamotrigine | 18 | $238 |
| Sertraline Hcl | 17 | $75 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Jacksonville Beach
- Mark GoldGainesville$355K
- Mark JacksonSaint Augustine$225K
- David KirbyLake City$183K
- George SchroederOrmond Beach$68K
- Brian GadboisTampa$50K
- Timothy GoodenNavarre$40K
- Malissa BarbosaOrlando$28K
- Thomas RineyPace$21K
- Rachael SanchezJacksonville$12K
- Miguel CorreaLeesburg$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.